Critical trial RESEARCH PROJECT DATA Public Ti
Post# of 148173
(Total Views: 599)
Posted On: 06/15/2021 2:03:16 PM
Critical trial
RESEARCH PROJECT DATA
Public Title: A phase 3, randomized, double-blind, placebo-controlled study to evaluate the efficacy and safety of Leronlimab in combination with standard treatment for critically ill patients with 2019 coronavirus pneumonia (COVID19) requiring mechanical ventilation or extracorporeal membrane oxygenation.
PI: REMO NETHERLANDS OF MENDONCA FURTADO
Public Contact: STOLEN MENDONCA NETHERLANDS REMO
Health conditions or problems studied: COVID19
Pneumonia
ICD Descriptors - General: COVID-19, virus identified
ICD Descriptors - Specific: COVID-19, virus identified
ICD - Intervention Descriptors: COVID-19, virus identified
CEP/CONEP Ethics Approval Date: 06/15/2021
DATA FROM THE PROPOSING INSTITUTION
DATA OF THE RESEARCH ETHICS COMMITTEE
Responsible Ethics Committee: 71 - Hospital Israelita Albert Einstein-SP
Address: Av. Albert Einstein 627 - 2ss
Phone: (11)2151-3729
E-mail: cep@einstein.br
RESEARCH PROJECT PARTICIPANT CENTRE(S)
RESEARCH PROJECT CO-PARTICIPANT CENTER(S)
https://plataformabrasil.saude.gov.br/login.jsf
RESEARCH PROJECT DATA
Public Title: A phase 3, randomized, double-blind, placebo-controlled study to evaluate the efficacy and safety of Leronlimab in combination with standard treatment for critically ill patients with 2019 coronavirus pneumonia (COVID19) requiring mechanical ventilation or extracorporeal membrane oxygenation.
PI: REMO NETHERLANDS OF MENDONCA FURTADO
Public Contact: STOLEN MENDONCA NETHERLANDS REMO
Health conditions or problems studied: COVID19
Pneumonia
ICD Descriptors - General: COVID-19, virus identified
ICD Descriptors - Specific: COVID-19, virus identified
ICD - Intervention Descriptors: COVID-19, virus identified
CEP/CONEP Ethics Approval Date: 06/15/2021
DATA FROM THE PROPOSING INSTITUTION
DATA OF THE RESEARCH ETHICS COMMITTEE
Responsible Ethics Committee: 71 - Hospital Israelita Albert Einstein-SP
Address: Av. Albert Einstein 627 - 2ss
Phone: (11)2151-3729
E-mail: cep@einstein.br
RESEARCH PROJECT PARTICIPANT CENTRE(S)
RESEARCH PROJECT CO-PARTICIPANT CENTER(S)
https://plataformabrasil.saude.gov.br/login.jsf
(12)
(0)CytoDyn Inc (CYDY) Stock Research Links
Scroll down for more posts ▼